Panayiotopoulos syndrome: Difference between revisions
CSV import |
CSV import |
||
| Line 38: | Line 38: | ||
{{stub}} | {{stub}} | ||
== Panayiotopoulos syndrome == | |||
<gallery> | |||
File:Illustrative_samples_of_EEG_from_14_children_with_Panayiotopoulos_syndrome.jpg|Illustrative samples of EEG from 14 children with Panayiotopoulos syndrome | |||
</gallery> | |||
Revision as of 02:06, 17 February 2025
Panayiotopoulos syndrome (also known as PS) is a relatively common epilepsy syndrome that affects children aged between 3 and 6 years old. It is characterized by seizures, often occurring during sleep, and is typically outgrown by adolescence.
Symptoms
The primary symptom of Panayiotopoulos syndrome is seizures. These seizures often occur during sleep and can last for several minutes to a few hours. The seizures are often accompanied by autonomic symptoms such as changes in skin color, heart rate, and pupil size. Other symptoms may include nausea, vomiting, and eye deviation.
Causes
The exact cause of Panayiotopoulos syndrome is unknown. However, it is believed to be genetic in nature, as it often runs in families. Some researchers believe that it may be related to a mutation in the CHRNA4 gene.
Diagnosis
Diagnosis of Panayiotopoulos syndrome is based on the child's symptoms and medical history. A neurological examination may be performed to rule out other conditions. Electroencephalogram (EEG) testing is often used to confirm the diagnosis.
Treatment
Treatment for Panayiotopoulos syndrome typically involves antiepileptic drugs (AEDs). These medications can help to control seizures and reduce their frequency. In some cases, a ketogenic diet may be recommended.
Prognosis
The prognosis for children with Panayiotopoulos syndrome is generally good. Most children outgrow the condition by adolescence and do not experience long-term neurological effects.


